For instance, KRASIM, the microprotein coded by the lncRNA NCBP2-AS2 has been found to suppress expression of KRAS and inhibit ERK signaling in hepatocellular carcinoma cells [79]. This evidence concerns the gene NCBP2AS2 and hepatocellular carcinoma.